Figure 1 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

Tadahiro Kuribayashi; Go Makimoto; Kadoaki Ohashi; Shuta Tomida; Hirofumi Inoue; Toshihide Yokoyama; Shoichi Kuyama; Yuka Kato; Kenichiro Kudo; Naokatsu Horita; Hiroe Kayatani; Masaaki Inoue; Keisuke Sugimoto; Kiichiro Ninomiya; Yoshinobu Maeda; Yosuke Togashi; Katsuyuki Hotta

doi:10.1158/2767-9764.31274946

Figure 1 from Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

2026 Open access

Read full text

Authors: Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, Shuta Tomida, Hirofumi Inoue, Toshihide Yokoyama, Shoichi Kuyama, Yuka Kato, Kenichiro Kudo, Naokatsu Horita, Hiroe Kayatani, Masaaki Inoue

+5 more

Keisuke Sugimoto, Kiichiro Ninomiya, Yoshinobu Maeda, Yosuke Togashi, Katsuyuki Hotta

DOI: 10.1158/2767-9764.31274946

Cited by: 0

Abstract

Kaplan–Meier curves for OS. Kaplan–Meier curve showing OS between the early resistance group (solid line) and the responder group (dashed line).

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Genomics and Diagnostics

Publication details

Publication date: 6 February 2026